Symphogen
Symphogen is an antibody Therapies founded in 2000.
5
Funding Rounds
$256.3m
Money raised
Overview
Symphogen is an antibody Therapies founded in 2000.
- Website:
- Business model: B2B
- Headquarters: Ballerup
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Symphogen has raised a total of $256.28m in funding over 5 rounds.
Key Insights:
- Symphogen funding round, May 2013: $53.77m
- Symphogen Series F round: $135.4m
- Symphogen funding round, February 2009: $42.11m
- Symphogen Series D round: $25m
Symphogen funding round, May 2013
$53.77m
Symphogen Series F round
$135.4m
Symphogen funding round, February 2009
$42.11m
Symphogen Series D round
$25m
Industries
Symphogen is active in the following industries: